Lycopene Prevents Mitochondrial Dysfunction during d‑Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats
Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. Th...
Saved in:
Published in | Journal of proteome research Vol. 16; no. 9; pp. 3190 - 3199 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
01.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF. |
---|---|
AbstractList | Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF. Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF.Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF. |
Author | Sheriff, Sheik Abdulazeez Pérez-Sánchez, Horacio Agarwal, Subhash Shaik Ibrahim, Shaikhussain Devaki, Thiruvengadam Chakraborty, Sandipan |
AuthorAffiliation | Universidad Católica San Antonio de Murcia (UCAM) Department of Computer Science and Engineering Department of Microbiology Bioinformatics Division University of Calcutta Bioinformatics and High Performance Computing Research Group (BIO-HPC), Computer Engineering Department Department of Biochemistry National Institute of Cancer Prevention and Research (NICPR-ICMR) Government College of Engineering |
AuthorAffiliation_xml | – name: National Institute of Cancer Prevention and Research (NICPR-ICMR) – name: Government College of Engineering – name: Bioinformatics Division – name: Bioinformatics and High Performance Computing Research Group (BIO-HPC), Computer Engineering Department – name: Department of Computer Science and Engineering – name: Universidad Católica San Antonio de Murcia (UCAM) – name: Department of Microbiology – name: University of Calcutta – name: Department of Biochemistry |
Author_xml | – sequence: 1 givenname: Sheik Abdulazeez surname: Sheriff fullname: Sheriff, Sheik Abdulazeez email: biosherif@yahoo.co.in organization: Department of Biochemistry – sequence: 2 givenname: Shaikhussain surname: Shaik Ibrahim fullname: Shaik Ibrahim, Shaikhussain organization: Government College of Engineering – sequence: 3 givenname: Thiruvengadam surname: Devaki fullname: Devaki, Thiruvengadam organization: Department of Biochemistry – sequence: 4 givenname: Sandipan surname: Chakraborty fullname: Chakraborty, Sandipan organization: University of Calcutta – sequence: 5 givenname: Subhash surname: Agarwal fullname: Agarwal, Subhash organization: National Institute of Cancer Prevention and Research (NICPR-ICMR) – sequence: 6 givenname: Horacio surname: Pérez-Sánchez fullname: Pérez-Sánchez, Horacio email: hperez@ucam.edu organization: Universidad Católica San Antonio de Murcia (UCAM) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28758404$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkctu1DAUhi1U1PsjgLxkk6kvSRyLVVWYttIgEKJry3FOqKvEDraDNDuWbHnFPkk9zAwLNrPykfz950jff4aOnHeA0BtKFpQweqVNXDxNwSfwIyxESwgV9St0SiteFVwScbSfG8lP0FmMTxmpBOHH6IQ1ompKUp6i36u18RM4wF8C_ASXIv5kkzeP3nXB6gF_WMd-diZZ73A3B-u-4-75159bPWiTfNSjdXC1spOf_LCO2phHHWwHxb3rZgMdXs5DRrRL-A4mnazBS22HOQC2Dl8PrXUef9UpXqDXvR4iXO7ec_Sw_Pjt5q5Yfb69v7leFZo3ZSpM09a9JBx4WbedgUoSBlJ2wCitpGZCCAOUGN1LyaToQUJVb3TUbSPbWvBz9G67N7v7MUNMarTRwDBoB36OipFaMEEqLg-iVLJSkpJxmtG3O3RuR-jUFOyow1rtRWfg_RYwwccYoFfGJr2xmkL2oShRm1pVrlX9q1Xtas3p6r_0_sChHN3m_n77Obis9kDmBQPKwFw |
CitedBy_id | crossref_primary_10_3892_br_2020_1310 crossref_primary_10_1016_j_biopha_2020_109818 crossref_primary_10_1016_j_ecoenv_2023_115122 crossref_primary_10_1016_j_jff_2018_02_005 crossref_primary_10_1016_j_lfs_2022_121131 crossref_primary_10_1016_j_jss_2021_04_039 crossref_primary_10_1021_acs_jafc_9b04323 crossref_primary_10_1016_j_jsps_2018_07_005 crossref_primary_10_3892_ijmm_2018_3830 crossref_primary_10_1016_j_envpol_2021_117080 crossref_primary_10_1016_j_psj_2021_101441 crossref_primary_10_3389_fphar_2019_00509 crossref_primary_10_1007_s11033_022_07661_1 crossref_primary_10_1038_s41598_021_93196_7 crossref_primary_10_3390_antiox9080706 crossref_primary_10_1089_jmf_2021_0134 crossref_primary_10_1038_s41598_024_60848_3 |
Cites_doi | 10.1016/j.jhep.2010.08.011 10.1152/ajpgi.00001.2006 10.1111/j.1600-0773.1995.tb00993.x 10.1021/pr0606326 10.1126/science.179.4073.588 10.1016/0304-4165(79)90289-7 10.1177/11.1.102 10.1016/j.jtusci.2013.01.002 10.1021/bi00510a001 10.1016/S0021-9258(18)57306-3 10.1016/S0021-9258(19)45228-9 10.1006/abbi.2000.2035 10.1093/jnci/djm037 10.1113/jphysiol.2003.049478 10.1016/j.fct.2008.07.016 10.1016/S0010-4655(98)00016-2 10.1124/mol.64.5.1136 10.1179/096805104225004879 10.1016/0008-8749(81)90411-1 10.1371/journal.pone.0050778 10.1021/bi971894b 10.1016/S0006-2952(96)00605-3 10.1016/S0891-5849(02)00740-2 10.1016/j.ejphar.2008.11.054 10.1007/s00198-006-0205-z 10.1093/bioinformatics/bti770 10.1007/s10495-011-0659-0 10.1016/j.phrs.2007.01.012 10.1016/j.fct.2008.10.026 10.1042/bj0520185 10.1016/j.ejphar.2011.01.030 10.1016/S0021-9258(19)77815-6 10.1016/j.cbi.2007.10.005 10.1093/nar/gkn314 10.1007/s11883-009-0065-z 10.1007/s11418-011-0544-8 10.1021/bi00039a035 10.1016/S0021-9258(18)93963-3 10.1177/09680519010070050501 10.1002/jcc.21256 10.1136/gut.30.6.854 10.3390/ijms14036306 10.1016/S2221-1691(13)60009-X 10.1016/j.ejphar.2011.12.027 10.1016/j.cbi.2008.09.036 10.1016/0003-2697(79)90738-3 10.1016/S0021-9258(19)52451-6 10.1002/pros.21190 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6 10.1016/0076-6879(67)10018-9 10.1007/s10620-007-9994-y 10.3109/10715762.2011.564168 10.1016/S0021-9258(19)42083-8 10.1016/0076-6879(69)13016-5 10.1016/S0378-4274(99)00062-4 10.1007/BF00769730 10.33549/physiolres.932041 10.3109/13880209.2013.803579 10.1002/lt.21931 10.1016/S0304-3940(99)00593-5 |
ContentType | Journal Article |
Copyright | Copyright © 2017 American Chemical Society |
Copyright_xml | – notice: Copyright © 2017 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1021/acs.jproteome.7b00176 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1535-3907 |
EndPage | 3199 |
ExternalDocumentID | 28758404 10_1021_acs_jproteome_7b00176 b980481941 |
Genre | Journal Article |
GroupedDBID | - 53G 55A 5GY 7~N AABXI ABMVS ABUCX ACGFS ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ CS3 DU5 EBS ED ED~ EJD F5P GNL IH9 IHE JG JG~ P2P RNS ROL UI2 VF5 VG9 W1F ZA5 --- 4.4 5VS AAHBH AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV AHGAQ BAANH CITATION CUPRZ GGK CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-a384t-c8b6f903e346bdce5902e99de21159a2777ce10caf99297fe9e5639076b89b673 |
IEDL.DBID | ACS |
ISSN | 1535-3893 1535-3907 |
IngestDate | Fri Jul 11 07:23:44 EDT 2025 Thu Jul 10 17:01:35 EDT 2025 Wed Feb 19 02:42:52 EST 2025 Thu Apr 24 23:01:45 EDT 2025 Tue Jul 01 01:05:37 EDT 2025 Thu Aug 27 13:41:54 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | electron transport free radicals TCA Cycle lipid peroxidation ATP |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a384t-c8b6f903e346bdce5902e99de21159a2777ce10caf99297fe9e5639076b89b673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 28758404 |
PQID | 1924904231 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2067270539 proquest_miscellaneous_1924904231 pubmed_primary_28758404 crossref_citationtrail_10_1021_acs_jproteome_7b00176 crossref_primary_10_1021_acs_jproteome_7b00176 acs_journals_10_1021_acs_jproteome_7b00176 |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N VG9 W1F ACS AEESW AFEFF ABMVS ABUCX IH9 AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20170901 2017-09-01 2017-Sep-01 |
PublicationDateYYYYMMDD | 2017-09-01 |
PublicationDate_xml | – month: 09 year: 2017 text: 20170901 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of proteome research |
PublicationTitleAlternate | J. Proteome Res |
PublicationYear | 2017 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 Misra H. P. (ref23/cit23) 1972; 247 ref45/cit45 ref3/cit3 ref63/cit63 ref56/cit56 ref16/cit16 ref52/cit52 ref8/cit8 ref59/cit59 ref2/cit2 Meister A. (ref51/cit51) 1988; 263 Lekić N. (ref62/cit62) 2011; 60 ref34/cit34 ref37/cit37 ref48/cit48 ref60/cit60 ref17/cit17 ref10/cit10 Padma P. (ref42/cit42) 1997; 34 ref35/cit35 ref53/cit53 ref19/cit19 ref21/cit21 Mehler A. H. (ref30/cit30) 1948; 174 ref46/cit46 Tretter L. (ref58/cit58) 1987; 19 ref49/cit49 ref13/cit13 ref61/cit61 King J. C. (ref27/cit27) 1965 ref50/cit50 ref54/cit54 ref6/cit6 ref36/cit36 ref18/cit18 ref11/cit11 ref25/cit25 ref29/cit29 ref32/cit32 ref39/cit39 ref14/cit14 ref57/cit57 ref5/cit5 ref43/cit43 ref28/cit28 ref40/cit40 Lowry O. H. (ref20/cit20) 1951; 193 Farber J. L. (ref38/cit38) 1990; 62 ref26/cit26 ref55/cit55 ref12/cit12 ref15/cit15 Habig W. H. (ref24/cit24) 1974; 249 ref41/cit41 ref22/cit22 ref33/cit33 ref4/cit4 ref47/cit47 ref1/cit1 Minakami S. (ref31/cit31) 1962; 237 ref44/cit44 ref7/cit7 |
References_xml | – ident: ref2/cit2 doi: 10.1016/j.jhep.2010.08.011 – ident: ref52/cit52 doi: 10.1152/ajpgi.00001.2006 – ident: ref41/cit41 doi: 10.1111/j.1600-0773.1995.tb00993.x – ident: ref4/cit4 doi: 10.1021/pr0606326 – ident: ref26/cit26 doi: 10.1126/science.179.4073.588 – ident: ref25/cit25 doi: 10.1016/0304-4165(79)90289-7 – ident: ref32/cit32 doi: 10.1177/11.1.102 – ident: ref14/cit14 doi: 10.1016/j.jtusci.2013.01.002 – ident: ref44/cit44 doi: 10.1021/bi00510a001 – volume: 174 start-page: 961 year: 1948 ident: ref30/cit30 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)57306-3 – volume: 247 start-page: 3170 year: 1972 ident: ref23/cit23 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)45228-9 – ident: ref17/cit17 doi: 10.1006/abbi.2000.2035 – ident: ref11/cit11 doi: 10.1093/jnci/djm037 – ident: ref59/cit59 doi: 10.1113/jphysiol.2003.049478 – start-page: 363 volume-title: Practical Clinical Enzymology year: 1965 ident: ref27/cit27 – ident: ref48/cit48 doi: 10.1016/j.fct.2008.07.016 – ident: ref36/cit36 doi: 10.1016/S0010-4655(98)00016-2 – ident: ref50/cit50 doi: 10.1124/mol.64.5.1136 – ident: ref5/cit5 doi: 10.1179/096805104225004879 – ident: ref22/cit22 doi: 10.1016/0008-8749(81)90411-1 – ident: ref63/cit63 doi: 10.1371/journal.pone.0050778 – ident: ref47/cit47 doi: 10.1021/bi971894b – ident: ref18/cit18 doi: 10.1016/S0006-2952(96)00605-3 – ident: ref43/cit43 doi: 10.1016/S0891-5849(02)00740-2 – ident: ref53/cit53 doi: 10.1016/j.ejphar.2008.11.054 – ident: ref12/cit12 doi: 10.1007/s00198-006-0205-z – ident: ref35/cit35 doi: 10.1093/bioinformatics/bti770 – ident: ref61/cit61 doi: 10.1007/s10495-011-0659-0 – ident: ref8/cit8 doi: 10.1016/j.phrs.2007.01.012 – ident: ref1/cit1 doi: 10.1016/j.fct.2008.10.026 – ident: ref29/cit29 doi: 10.1042/bj0520185 – ident: ref60/cit60 doi: 10.1016/j.ejphar.2011.01.030 – volume: 263 start-page: 17205 year: 1988 ident: ref51/cit51 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)77815-6 – ident: ref57/cit57 doi: 10.1016/j.cbi.2007.10.005 – ident: ref37/cit37 doi: 10.1093/nar/gkn314 – ident: ref9/cit9 doi: 10.1007/s11883-009-0065-z – ident: ref39/cit39 doi: 10.1007/s11418-011-0544-8 – ident: ref40/cit40 doi: 10.1021/bi00039a035 – volume: 237 start-page: 569 year: 1962 ident: ref31/cit31 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)93963-3 – ident: ref6/cit6 doi: 10.1177/09680519010070050501 – ident: ref34/cit34 doi: 10.1002/jcc.21256 – volume: 62 start-page: 670 year: 1990 ident: ref38/cit38 publication-title: Lab Invest. – ident: ref49/cit49 doi: 10.1136/gut.30.6.854 – ident: ref54/cit54 doi: 10.3390/ijms14036306 – ident: ref15/cit15 doi: 10.1016/S2221-1691(13)60009-X – ident: ref56/cit56 doi: 10.1016/j.ejphar.2011.12.027 – ident: ref46/cit46 doi: 10.1016/j.cbi.2008.09.036 – ident: ref21/cit21 doi: 10.1016/0003-2697(79)90738-3 – volume: 193 start-page: 265 year: 1951 ident: ref20/cit20 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)52451-6 – ident: ref10/cit10 doi: 10.1002/pros.21190 – ident: ref33/cit33 doi: 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6 – ident: ref19/cit19 doi: 10.1016/0076-6879(67)10018-9 – ident: ref7/cit7 doi: 10.1007/s10620-007-9994-y – ident: ref13/cit13 doi: 10.3109/10715762.2011.564168 – volume: 249 start-page: 7130 year: 1974 ident: ref24/cit24 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)42083-8 – ident: ref28/cit28 doi: 10.1016/0076-6879(69)13016-5 – ident: ref55/cit55 doi: 10.1016/S0378-4274(99)00062-4 – volume: 34 start-page: 296 year: 1997 ident: ref42/cit42 publication-title: Indian J. Biochem. Biophys. – volume: 19 start-page: 21 year: 1987 ident: ref58/cit58 publication-title: J. Bioenergy Biomembr. doi: 10.1007/BF00769730 – volume: 60 start-page: 549 year: 2011 ident: ref62/cit62 publication-title: Physiol. Res. doi: 10.33549/physiolres.932041 – ident: ref16/cit16 doi: 10.3109/13880209.2013.803579 – ident: ref3/cit3 doi: 10.1002/lt.21931 – ident: ref45/cit45 doi: 10.1016/S0304-3940(99)00593-5 |
SSID | ssj0015703 |
Score | 2.3270118 |
Snippet | Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3190 |
SubjectTerms | adenosine triphosphate Adenosine Triphosphate - agonists Adenosine Triphosphate - antagonists & inhibitors Adenosine Triphosphate - biosynthesis albino Animals antioxidant activity Antioxidants - chemistry Antioxidants - pharmacology Binding Sites body weight Carotenoids - chemistry Carotenoids - pharmacology Chemical and Drug Induced Liver Injury - drug therapy Chemical and Drug Induced Liver Injury - metabolism Chemical and Drug Induced Liver Injury - pathology Citric Acid Cycle - drug effects electron transport chain Electron Transport Chain Complex Proteins - agonists Electron Transport Chain Complex Proteins - antagonists & inhibitors Electron Transport Chain Complex Proteins - metabolism enzyme activity enzymes Galactosamine - toxicity hydrogen peroxide Hydrogen Peroxide - antagonists & inhibitors Hydrogen Peroxide - metabolism lipid peroxidation Lipid Peroxidation - drug effects lipid peroxides Lipopolysaccharides - toxicity Lipoxygenase Inhibitors - chemistry Lipoxygenase Inhibitors - pharmacology Lipoxygenases - chemistry Lipoxygenases - metabolism Liver liver failure Liver Failure, Acute - chemically induced Liver Failure, Acute - drug therapy Liver Failure, Acute - metabolism Liver Failure, Acute - pathology lungs lycopene Male mitochondria Mitochondria - drug effects Mitochondria - metabolism Mitochondria - pathology mitochondrial membrane Molecular Docking Simulation molecular models neoplasms Oxidative Stress Protein Binding Protein Interaction Domains and Motifs Protein Structure, Secondary proteome Rats Rats, Wistar toxicity tricarboxylic acid cycle |
Title | Lycopene Prevents Mitochondrial Dysfunction during d‑Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats |
URI | http://dx.doi.org/10.1021/acs.jproteome.7b00176 https://www.ncbi.nlm.nih.gov/pubmed/28758404 https://www.proquest.com/docview/1924904231 https://www.proquest.com/docview/2067270539 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADB6VcoAL78fy0iBxQkqa17yO1cKyQgUhoFJv0WTGkbZss1WTPWxPHLnyF_kl2JNkJYRWhWsU5zFjjz_L9mfGXgmncwylZSTBi6hIbRpZIWzka6itziubuVDl-1HOj4v3J-Jkjx3syOBn6YF1bXwaSAtWZxCrELXIa-x6JtGQCQtNv2zTBkQn1ROkiog88diys-sx5JJc-6dL2oEzg7-Z3Wafxq6dvszkW7zuqthd_k3i-K-_cofdGrAnP-yV5S7bg-YeuzEdR77dZz-ONtSk0gAfmJ1a_gEtHk_IxpOi8jeblhwhbSbvGxy5__X95zu7pLE9rT0j1o2jxTlNXti01lFP18JDRANCHHiOAW9fesPnQKXcjs_sggrj-aLhh0uM0lf8s-3aB-x49vbrdB4Noxoim-uii5yuZG2SHPJCVp5au5IMjPGA8aUwNlNKOUgTZ2uDeEzVYEAgNkqUrLSppMofsv1m1cBjxjXKOq19UlhVOFAWAWklc-trI7zO6wl7jetYDqbWliGLnqVluDgubjks7oQV49aWbiA9p9kby6vE4q3Yec_6cZXAy1FvStwzSrrYBlZr_DwKcKn4KN19Txby4Xgcmgl71Cvd9rUY0SJGTIon__PbT9nNjOBHqIV7xva7izU8R_DUVS-CwfwG9ccb7w |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELZKOZQL70eggJE4ITns049jFAgB0h6gFb2tvLZXCqSbCm8O4cSRa_9if0lnvLtBIEVVr9ba68fY841m5htCXudGpmBKc8adzVkW65jpPNfMVq7SMi11YkKU7yGfHmefTvKTHcL7XBiYhIeRfHDi_2UXiN9i2_fAXbA8dUMRjBd-g9wEQJKgZI_GXzfeA2SVanlSc4YKuc_c2TYMaibj_9VMW-BmUDuTO-TbZsIh2uTHcNWUQ_PrPy7H66_oLrndIVE6akXnHtlx9X2yN-4LwD0gf2ZrTFmpHe14njw9gPsP72VtUWzpu7VHtYhHS9t0R2ovfp9_0Ass4uP1KXJwzOZnWIdh7bXBDK-5dQzLhRhnKZi_bSAOnToM7DZ0oucYJk_nNR0twGZf0i-68Q_J8eT90XjKusINTKcya5iRJa9UlLo046XFRK8ocUpZB9ZmrnQihDAujoyuFKAzUTnlckBKkeClVCUX6SOyWy9r94RQCX2NlDbKtMiMExrgaclTbSuVW5lWA_IG9rHoLp4vgk89iYvQ2G9u0W3ugGT9CRemo0DHShyLq7oNN93OWg6Qqzq86sWngDNDF4yu3XIF00NzF0OR4u3fJME7Do-jGpDHrextfgv2LSDGKHt6nWW_JHvTo4NZMft4-PkZuZUgMAlRcvtkt_m5cs8BVjXli3CHLgGV5yRQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgkYDLLm_K8jASJySXvPzIsepSCpQVAlZaiUPk2I5U6KYVTg_dE0eu_EV-CTNOUgmkagVXK3b8GHtmNN98Q8gzblQKrrRgwlnOsljHTHOuma1cpVVa6sQElO-xmJ5kb075aYeqxFwYmISHkXwI4uOtXtmqYxiIX2D7l8BfsDxzQxkcGHGZXMHQHUr3aPxxG0FAZqmWK5UzVMp99s6uYVA7Gf-ndtphcgbVMzkgn7eTDoiTr8N1Uw7N-V98jv-3qhtkv7NI6agVoZvkkqtvkWvjvhDcbfJjtsHUldrRju_J03fwDsC7WVsUX3q08age8Yhpm_ZI7a_vP1_pBRbz8foMuThm8xXWY9h4bTDTa24dw7IhxlkKbnALyKFThwBvQyd6jnB5Oq_paAG--5J-0I2_Q04mLz-Np6wr4MB0qrKGGVWKKo9Sl2aitJjwFSUuz60Dr5PnOpFSGhdHRlc5WGmycrnjYDFFUpQqL4VM75K9elm7-4Qq6GuUslGmZWac1GCmliLVtsq5VWk1IM9hH4vuAvoixNaTuAiN_eYW3eYOSNafcmE6KnSsyLG4qNtw223VcoFc1OFpL0IFnBmGYnTtlmuYHrq9CEmKd3-ThCg5PJL5gNxr5W_7W_BzwXKMsgf_suwn5Or7o0kxe3389pBcT9A-CWC5h2Sv-bZ2j8C6asrH4Rr9BrywJtM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lycopene+Prevents+Mitochondrial+Dysfunction+during+d-Galactosamine%2FLipopolysaccharide-Induced+Fulminant+Hepatic+Failure+in+Albino+Rats&rft.jtitle=Journal+of+proteome+research&rft.au=Sheriff%2C+Sheik+Abdulazeez&rft.au=Shaik+Ibrahim%2C+Shaikhussain&rft.au=Devaki%2C+Thiruvengadam&rft.au=Chakraborty%2C+Sandipan&rft.date=2017-09-01&rft.issn=1535-3907&rft.eissn=1535-3907&rft.volume=16&rft.issue=9&rft.spage=3190&rft_id=info:doi/10.1021%2Facs.jproteome.7b00176&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-3893&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-3893&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-3893&client=summon |